Go to the list of all blogs
Dem Sem's Avatar
published in Blogs
Feb 26, 2026
TickeronGET DAILY SIGNALS
Linde plc (LIN) Stock Analysis: Strong Execution Meets Conservative Outlook

Linde plc (LIN) Stock Analysis: Strong Execution Meets Conservative Outlook

Key Takeaways

  • Linde (LIN) reported Q4 2025 adjusted EPS of $4.20, topping estimates, with full-year revenue reaching $34 billion.

  • 2026 EPS guidance of $17.40–$17.90 implies 6–9% growth, supported by a record $10 billion project backlog.

  • Analyst consensus price target sits near $509, reflecting a generally constructive outlook despite mixed rating changes.

  • Shares dipped after earnings on cautious guidance but have since stabilized.

  • Restructuring initiatives and clean energy investments position Linde for potential margin expansion in 2026.

  • Street forecasts call for roughly 4.4% revenue growth to $35.5 billion next year.

Market Snapshot: Premium Valuation, Steady Fundamentals

Linde plc shares have navigated a volatile industrial backdrop with relative resilience. After an initial post-earnings pullback, the stock has recovered and stabilized, reflecting investor confidence in its strong cash flow profile and high-visibility project pipeline.

Operating margins remain best-in-class within the industrial gases sector, supported by disciplined pricing and ongoing productivity initiatives. While traditional manufacturing volumes face pressure, growth in electronics, clean energy, and specialty gases continues to anchor the long-term thesis.

Earnings Review: Beat on Results, Caution on Outlook

Linde’s Q4 2025 results modestly exceeded expectations:

  • Adjusted EPS: $4.20 (vs. $4.18 consensus)

  • Revenue: $8.76 billion (up 6.3% year-over-year)

  • Operating cash flow: $3.0 billion (up 8%)

Full-year revenue reached $34 billion, with underlying sales growth of 3%, driven by 2% pricing gains and 1% volume growth from project startups.

The company returned $7.4 billion to shareholders in 2025 through dividends and buybacks, underscoring its commitment to capital returns.

Why Shares Initially Declined

Despite the earnings beat, shares fell more than 2% following the release. The reaction stemmed from 2026 guidance viewed as conservative:

  • Full-year 2026 EPS guidance: $17.40–$17.90

  • Q1 2026 EPS guidance: $4.20–$4.30

The midpoint of full-year guidance came in slightly below consensus expectations of $17.83. Management assumed flat base volumes and a modest 1% foreign exchange tailwind, reflecting ongoing softness in manufacturing and chemicals.

Project Backlog: Growth Visibility Into 2026

A central pillar of Linde’s investment case is its record $10 billion project backlog — approximately two-thirds tied to clean energy initiatives.

Management expects $2.5–$3.0 billion in projects to begin operations during 2026, providing incremental revenue visibility. Key areas include:

  • Hydrogen infrastructure

  • Carbon capture and storage

  • Electronics and semiconductor-related gases

Demand linked to AI-driven semiconductor production continues to offset cyclical industrial weakness in other segments.

Analyst Reaction: Mixed but Generally Constructive

Analyst responses following earnings were varied:

Downgrades:

  • JPMorgan lowered its rating to Neutral from Overweight, citing flat organic growth and potential pricing pressures.

  • DZ Bank downgraded to Hold from Buy.

Target Increases and Positive Views:

  • Morgan Stanley raised its target to $530 (Buy).

  • UBS lifted its target to $550.

  • Citi increased its target to $545.

  • Mizuho raised its target to $525.

  • BMO Capital moved its target to $507 (Outperform).

Consensus price targets cluster around $509–$510, suggesting moderate upside from recent trading levels near $468.

Restructuring and Margin Expansion

Linde recorded $230 million in restructuring charges during Q4 as part of cost optimization efforts. Benefits are expected to materialize in the second half of 2026.

Management continues to target annual margin expansion of 30–50 basis points, driven by:

  • Productivity improvements

  • Portfolio optimization

  • Pricing discipline

  • Network density efficiencies

Helium and rare gas oversupply created a 1–2% EPS headwind during the quarter, but long-term fundamentals in specialty gases remain intact.

Capital expenditures are guided to $5.0–$5.5 billion in 2026, supporting backlog execution and growth projects.

2026 Outlook: Key Factors to Watch

1. Clean Energy and Electronics Momentum

Execution on backlog projects — particularly hydrogen and electronics-related facilities — will be critical. Semiconductor capacity expansion and AI infrastructure growth remain structural demand drivers for specialty gases.

2. Industrial Volume Recovery

European manufacturing weakness and global industrial softness remain near-term headwinds. A cyclical recovery could provide incremental upside beyond current guidance assumptions.

3. Margin Discipline

Investors will monitor whether restructuring benefits exceed the historical 30–50 basis point annual expansion range. Return on capital remains strong in the low-to-mid 20% range despite elevated CapEx.

4. Commodity and Specialty Gas Pricing

Helium oversupply and rare gas pricing pressures bear watching, particularly if industrial demand remains subdued.

Bottom Line

Linde continues to demonstrate operational discipline, strong cash generation, and long-term growth visibility through its record backlog. While conservative 2026 guidance prompted an initial selloff, underlying fundamentals — including pricing power, clean energy investments, and semiconductor-driven demand — remain intact.

Tickeron AI Perspective

Disclaimers and Limitations

Related Ticker: LIN

Contributor

Dem Sem's AvatarDem Sem|Expert

LIN's RSI Indicator is staying in overbought zone for 8 days

The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 12 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where LIN declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 45%.

LIN broke above its upper Bollinger Band on October 22, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on September 23, 2026. You may want to consider a long position or call options on LIN as a result. In 53 of 88 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 60%.

The Moving Average Convergence Divergence (MACD) for LIN just turned positive on September 23, 2026. Looking at past instances where LIN's MACD turned positive, the stock continued to rise in 26 of 46 cases over the following month. The odds of a continued upward trend are 57%.

LIN moved above its 50-day moving average on October 05, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for LIN crossed bullishly above the 50-day moving average on October 08, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 8 of 14 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 57%.

Following a +2.07% 3-day Advance, the price is estimated to grow further. Considering data from situations where LIN advanced for three days, in 152 of 322 cases, the price rose further within the following month. The odds of a continued upward trend are 47%.

The Aroon Indicator entered an Uptrend today. In 105 of 252 cases where LIN Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 42%.

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is 13 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 81, placing this stock better than average.

The Tickeron PE Growth Rating for this company is 36 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 45 (best 1 - 100 worst), indicating steady price growth. LIN’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 48 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Seasonality Score of 75 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of 82 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.994) is normal, around the industry mean (2.411). P/E Ratio (32.637) is within average values for comparable stocks, (-17.460). Projected Growth (PEG Ratio) (1.827) is also within normal values, averaging (1.548). Dividend Yield (0.013) settles around the average of (0.040) among similar stocks. P/S Ratio (6.094) is also within normal values, averaging (48.960).

Notable companies

The most notable companies in this group are DuPont de Nemours (NYSE:DD), Chemours Company (The) (NYSE:CC).

Industry description

The specialty chemicals sector includes companies that produce chemicals and industrial gases, which are of relatively high-value, often made to customer specifications. Examples of specialty chemicals are electronic chemicals, industrial gases, coatings, adhesives and sealants, industrial and institutional cleaning chemicals. The products are often valued on the basis of their purposes/performances rather than for their composition. Linde Plc, Ecolab Inc., Air Products and Chemicals, Inc., and Dow, Inc. are some of the largest companies making specialty chemicals.

Market Cap

The average market capitalization across the Chemicals: Specialty Industry is 11.59B. The market cap for tickers in the group ranges from 50 to 234.25B. LIN holds the highest valuation in this group at 234.25B. The lowest valued company is JSCPY at 50.

High and low price notable news

The average weekly price growth across all stocks in the Chemicals: Specialty Industry was 2%. For the same Industry, the average monthly price growth was -0%, and the average quarterly price growth was -6%. SNES experienced the highest price growth at 29%, while LOOP experienced the biggest fall at -18%.

Volume

The average weekly volume growth across all stocks in the Chemicals: Specialty Industry was -7%. For the same stocks of the Industry, the average monthly volume growth was -2% and the average quarterly volume growth was -34%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 53
P/E Growth Rating: 54
Price Growth Rating: 54
SMR Rating: 78
Profit Risk Rating: 81
Seasonality Score: 21 (-100 ... +100)
View a ticker or compare two or three
LIN
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a producer of industrial gas

Industry ChemicalsSpecialty

Industry
Chemicals Specialty
Address
10 Riverview Drive
Phone
+1 203 837-2000
Employees
65177
Web
https://www.linde.com
Interact to see
Advertisement
The Bitwise Solana Staking ETF (BSOL) advanced roughly 18% over the trailing 30 days, closely tracking a sharp rally in Solana (SOL). The move extends a broader recovery, with BSOL up approximately 77% over the past three months from its mid-2026 trough.
MSTY is an actively managed single-stock option income ETF (exchange-traded fund) that writes call options on Strategy (MSTR), formerly MicroStrategy, to generate current income. The portfolio is anchored by U.S. Treasury bills and MSTR option contracts rather than a diversified basket of equities, concentrating exposure in one volatile underlying.
AMDL has surged roughly +64% over the past 30 days, from about $47.59 to $78.10, mirroring a powerful rally in its sole underlying stock, AMD . The fund is a leveraged single-stock ETF (exchange-traded fund) designed to deliver 2x the daily return of AMD, amplifying both gains and losses.
TSMX, a 2x daily leveraged single-stock ETF (exchange-traded fund), rose roughly +19% over the trailing 30 days, rebounding sharply from mid-September lows. The fund seeks 200% of the daily return of TSM (Taiwan Semiconductor Manufacturing), meaning its moves are roughly double the underlying stock's daily swings.
Contracted revenue anchor: A roughly $3.2 billion, seven-year LNG (liquefied natural gas) supply agreement with Puerto Rico has received final approval, providing multi-year cash-flow visibility if execution stays on track. Project pipeline inflection: Upcoming milestones include the Barcarena and PortoCem power plants in Brazil, a potential Gás Sul terminal restart, and optimization of the company's modular "Fast LNG" (FLNG) liquefaction fleet.
AMD (Advanced Micro Devices) designs central processing units (CPUs), graphics processing units (GPUs), and AI accelerators, while LRCX (Lam Research) supplies the wafer-fabrication equipment used to build advanced chips. AMD has delivered strong double-digit revenue growth on AI data-center demand, but its shares trade with elevated expectations that can trigger sharp reactions around earnings.
Origination momentum: Velocity Financial enters 2026 off record annual originations of roughly $2.7 billion (up about 48%), positioning it to keep gaining share in a fragmented investor-loan market. Credit normalization is the central watch item: Nonperforming loans fell toward the 8.5% range of portfolio unpaid principal balance (UPB), but asset quality remains the primary swing factor for earnings.
Turnaround milestone ahead: Management has pointed to reaching cash generation in 2027, making the pace of cost discipline and margin recovery the central question for the stock forecast. Fresh capital supports execution: A recently announced $45.5 million equity financing, with participation from management and a single institutional investor, strengthens the balance sheet as the company funds its transformation.
NFE closed at $5.51, down -6.13% during Tuesday's regular session, extending a slide that has pushed shares near a 52-week low. Primary catalyst: the company disclosed its Fast LNG unit is offline after a gas-turbine mechanical failure, with return to service not expected until Q4.
The central $11 target is the arithmetic mean of four verified analyst price targets, rounded from roughly $10.75. With the stock near $2.06, reaching $11 would require an upside of more than 400%, an extremely large move.
The $23 central target is the rounded arithmetic mean of four verified analyst price targets, which average $23.25. The latest verified price is around $9.57, meaning the target implies roughly 140% upside—a very large move.
NXH closed down -11.17% (-$0.23) to $1.83 on Oct 6, the most recent regular session, extending a steep two-day decline. Selling continued as investors digested the mutual termination of the Fathom Holdings merger and a dilutive $45.5M registered direct offering of ~16.5M shares at $2.76.
AMD is a large-cap designer of CPUs (central processing units) and GPUs (graphics processing units) competing directly with Nvidia in the AI accelerator market, while FORM is a small-cap provider of semiconductor test and measurement equipment, primarily probe cards. AMD's narrative has been driven by multi-billion-dollar hyperscaler deals, while FORM's has been powered by record revenue and sharp margin expansion tied to high-bandwidth memory (HBM) demand.
AMD has surged roughly 200% year to date, crossing a $1 trillion market capitalization on AI data-center demand and a "CPU renaissance" narrative. KLAC has gained about 71% year to date, supported by record process-control revenue and rapid growth in advanced packaging for AI chips.
AMD is a large-cap semiconductor designer riding explosive AI compute demand, while ENTG is a mid-cap supplier of materials and purity solutions that feed the same AI-driven chip cycle. AMD recently crossed a $1 trillion market capitalization on surging data center revenue, whereas ENTG operates at a far smaller scale (roughly $23 billion) with steadier, double-digit growth.
VELO closed Tuesday at $9.57, unchanged (+0.00%) from the prior session, with the move occurring during regular market hours. The flat close marked stabilization after Monday's -14.5% plunge, when shares fell to $9.57 from $11.20 following disclosure of CFO James Suva's departure.
The $8 target used here is a technical, publicly discussed recovery objective — not an analyst consensus — because legacy analyst price targets were set before NFE's restructuring and reverse stock split. New Fortress Energy Inc. ( NFE ) trades near $5.51, so reaching $8 implies a roughly 45% advance.
AVBP plunged -46.98% during Tuesday's regular session, closing at $15.09 versus $28.46, marking its worst single-day decline on record. The catalyst was the Phase 3 FURVENT trial of firmonertinib failing its primary endpoint—progression-free survival—in first-line EGFR exon 20 insertion non-small cell lung cancer.
Upcoming catalyst: The company's next earnings release is estimated for November 6, 2026, which should offer fresh detail on its SKY token holdings, staking rewards, and treasury strategy. Strategic positioning: SDEV is an on-chain holding company providing public-market exposure to the Sky protocol ecosystem, with SKY as its core digital asset and a stated focus on the stablecoin economy.
Different roles in the chip ecosystem: AMAT is a materials-engineering and deposition leader, while KLAC dominates process control, inspection, and yield management. Momentum favors AMAT: AMAT shares have more than doubled this year, while KLAC has recently pulled back roughly 9% in a month on margin and execution concerns.